The company is predicting an adjusted revenue of $500 to $520 million and profit of $0.24 to $0.29 per share, significantly lower than the expected $540.5 million revenue and $0.34 profit. The announcement caused Nuance shares to tumble almost 10 percent Monday, according to the report.
“Nuance continues to be a work in progress as the company transitions to a subscription-based model and still faces some growth challenges in the field,” FBR Capital Markets analyst Daniel Ives told Reuters.
More articles on Nuance:
4 Key Findings on How Physicians View CDI Technology and Processes
5 Notable Stories on ICD-10
8 Recent Health IT Market Stories
